Microbial signatures and host immune responses associated with the development of ventilator-associated pneumonia among patients with neurological injuries
Open Access
- 5 May 2026
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (5) , e0319325
Abstract
Ventilator-associated pneumonia (VAP) remains a leading complication in mechanically ventilated patients, yet the contribution of the respiratory microbiota remains poorly understood. The PULMIVAP study is a multicenter, longitudinal cohort investigation of respiratory microbiota composition and host immune responses in critically ill adults intubated for non-pulmonary conditions. A total of 146 intubated adult patients were enrolled across eight Italian ICUs, forming matched groups of 73 with VAP and 73 without. Oropharyngeal swabs and endotracheal aspirates were collected at intubation and either at VAP diagnosis or at a matched point in controls for a total of 584 biological samples. Metataxonomic analyses revealed substantial temporal shifts in microbial communities across both upper and lower respiratory compartments, with a trend toward reduced microbial richness in patients who developed VAP. Several genera, such as Corynebacterium, were more abundant in no-VAP patients, whereas Escherichia-Shigella and Peptoniphilus were enriched in VAP samples. Cytokine-microbiota correlation analysis suggested a pro-inflammatory signature in VAP patients, with Citrobacter positively associated with IFN-γ and TNF-α, while several commensal genera were inversely correlated with inflammatory mediators. Additionally, taxa associated with VAP correlated with lower PaO 2 /FiO 2 ratios, implicating them in disease severity. Consistently, several bacteria, such as Corynebacterium , appeared to be linked to better respiratory outcomes, suggesting protective or risk-associated microbial profiles. Overall, these findings highlight the complex interplay between microbial communities and mucosal immunity in the pathogenesis of VAP. The identification of condition-associated microbial and immunological signatures may inform future strategies for risk stratification and targeted prevention. IMPORTANCE: Ventilator-associated pneumonia (VAP) remains a major complication of mechanical ventilation, yet most microbiome studies have focused on late-stage infection or single airway compartments, limiting insight into early microbial dynamics associated with VAP risk. By longitudinally characterizing upper and lower airway microbiota before and during VAP development, this study provides new insights into microbial and immune patterns associated with susceptibility and disease severity in humans. These findings contribute to the current understanding of VAP pathogenesis by suggesting a role for early airway dysbiosis and local immune responses alongside clinical factors. Remarkably, the identification of taxa associated with risk or protection supports the potential for microbiota-informed monitoring and future risk stratification strategies during mechanical ventilation. CLINICAL TRIALS: This study is registered with ClinicalTrials.gov as NCT04849039 .Keywords
This publication has 53 references indexed in Scilit:
- The ongoing challenge of ventilator-associated pneumonia: epidemiology, prevention, and risk factors for mortality in a secondary care hospital intensive care unitInfection Prevention in Practice, 2023
- A pulmonary abscess caused by Porphyromonas endodontalis infection:A case report and literature reviewDiagnostic Microbiology and Infectious Disease, 2023
- Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infectionLife Sciences, 2023
- Lung microbiome and origins of the respiratory diseasesCurrent Research in Immunology, 2023
- The role of microbiota in respiratory health and diseases, particularly in tuberculosisBiomedicine & Pharmacotherapy, 2021
- Porphyromonas: A neglected potential key genus in human microbiomesAnaerobe, 2021
- The impact of e-training on tooth wear assessments using the BEWEJournal of Dentistry, 2020
- The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapyCellular and Molecular Life Sciences, 2020
- Identification of respiratory microbiota markers in ventilator-associated pneumoniaIntensive Care Medicine, 2019
- Interplay between the lung microbiome and lung cancerCancer Letters, 2018